10X Genomics Inc Class A (TXG)

Cost of Revenue

$38.54M

Quarterly · Period ending: · USD

TXG logo

TXG Cost of Revenue

Latest reported$38.54M
TXG Quarterly Cost of Revenue ($4.26M → $38.54M)
High-resolution chart · PNG

TXG cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

10X Genomics Inc Class A Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
38,539,000
44,665,000
52,985,000
48,695,000
47,824,000
49,438,000
54,066,000
45,261,000
48,884,000
48,092,000
68,197,000
58,115,000
47,207,000
35,895,000
36,827,000
30,377,000
27,704,000
25,478,000
27,598,000
24,518,000
4,915,000
17,060,000
18,897,000
14,411,000
10,052,000
15,108,000
16,582,000
15,480,000
15,006,000
13,965,000
14,900,000
5,241,000
4,550,000
4,260,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.